FOLFIRINOX Induction Chemotherapy for Synchronous Liver Metastases | MicrobiomeTrials← Back to trialsNCT07467434
FOLFIRINOX Induction Chemotherapy for Synchronous Liver Metastases
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-05-01Est. Completion: 2030-11-01
Enrollment target: 550 participants Locations- Digestive Surgery Department, Bicêtre University Hospital AP-HP, Le Kremlin-Bicêtre, France
Other microbiome trials you might be interested in
Colorectal Cancer
This is a Phase 1/2 open-label, multicenter study evaluating the safety and efficacy of LYL273 in participants with rela…
Duarte, United StatesEst. completion Jun 2028
Breast CancerGastric CancerEsophageal CancerGastroesophageal CancerColorectal CancerEndometrial CancerNon-small Cell Lung CancerOvarian CancerUrothelial Carcinoma
Salivary Gland Cancer
Pancreatic Cancer
HER-2 Protein Overexpression
The purpose of this study is to evaluate the efficacy and safety of zanidatamab for the treatment of participants with p…
Prescott, United StatesEst. completion Dec 31, 2026
AdenocarcinomaProstate CancerNeoplasmsCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type
Background:
Prostate cancer is the second most common cause of cancer-related death among men in the United States. Ear…
Bethesda, United StatesEst. completion Jun 15, 2027